MannKind shares are trading higher after Oppenheimer maintained an Outperform rating on the stock and raised its price target from $10 to $12.
Portfolio Pulse from Benzinga Newsdesk
MannKind shares rose after Oppenheimer maintained an Outperform rating and increased its price target from $10 to $12.
August 28, 2024 | 4:46 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
MannKind shares are trading higher following Oppenheimer's decision to maintain an Outperform rating and raise the price target from $10 to $12.
The increase in price target and maintained Outperform rating by Oppenheimer is a positive signal to investors, likely leading to increased buying interest and a short-term rise in MannKind's stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100